Celltrio
Private Company
Total funding raised: $2.5M
Overview
Celltrio is a private, revenue-generating company specializing in modular robotic automation for cell therapy and biologics manufacturing. Its core technology, the RoboCell platform, automates complex cell culture workflows, supported by a software suite (Bioflow) and a cryogenic storage system (RoboStor). The company leverages proven, patented IP from a Korean robotics partner and is led by an experienced executive team with deep robotics and automation expertise, positioning it to address scalability challenges in the rapidly growing cell and gene therapy market.
Technology Platform
Modular robotic automation platform (RoboCell) composed of standardized task modules for end-to-end cell culture and biobanking, integrated with Bioflow workflow software and RoboStor cryogenic storage.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Celltrio competes in the lab automation space against large diversified players like Thermo Fisher Scientific and Sartorius, as well as specialized automation firms. Its differentiation lies in its fully integrated, modular platform specifically designed for complex, multi-line cell culture workflows, a focus area less served by general-purpose liquid handlers.